Fidelity Investments’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$104M Sell
8,996,404
-896,735
-9% -$10.4M 0.01% 1102
2025
Q1
$86.4M Sell
9,893,139
-3,561,295
-26% -$31.1M 0.01% 1151
2024
Q4
$193M Buy
13,454,434
+86,455
+0.6% +$1.24M 0.01% 838
2024
Q3
$302M Buy
13,367,979
+357,470
+3% +$8.07M 0.02% 664
2024
Q2
$253M Buy
13,010,509
+81,260
+0.6% +$1.58M 0.02% 702
2024
Q1
$485M Buy
12,929,249
+143,713
+1% +$5.39M 0.03% 465
2023
Q4
$715M Buy
12,785,536
+118,538
+0.9% +$6.63M 0.06% 314
2023
Q3
$523M Buy
12,666,998
+4,565,400
+56% +$188M 0.05% 372
2023
Q2
$452M Buy
8,101,598
+3,729,304
+85% +$208M 0.04% 446
2023
Q1
$244M Buy
4,372,294
+1,169,928
+37% +$65.3M 0.02% 633
2022
Q4
$117M Sell
3,202,366
-509,836
-14% -$18.6M 0.01% 911
2022
Q3
$106M Sell
3,712,202
-2,483,325
-40% -$70.7M 0.01% 936
2022
Q2
$280M Buy
6,195,527
+2,070,318
+50% +$93.7M 0.03% 582
2022
Q1
$314M Sell
4,125,209
-3,062,865
-43% -$233M 0.03% 614
2021
Q4
$1.07B Sell
7,188,074
-1,177,765
-14% -$175M 0.08% 225
2021
Q3
$1.22B Buy
8,365,839
+467,613
+6% +$68.1M 0.1% 173
2021
Q2
$1.55B Sell
7,898,226
-1,843,937
-19% -$361M 0.12% 139
2021
Q1
$1.76B Sell
9,742,163
-328,920
-3% -$59.5M 0.15% 118
2020
Q4
$1.43B Buy
10,071,083
+1,484,389
+17% +$210M 0.13% 143
2020
Q3
$1.07B Buy
8,586,694
+1,398,273
+19% +$174M 0.11% 167
2020
Q2
$642M Buy
7,188,421
+3,996,052
+125% +$357M 0.07% 244
2020
Q1
$199M Buy
3,192,369
+57,291
+2% +$3.57M 0.03% 505
2019
Q4
$239M Buy
3,135,078
+385,217
+14% +$29.4M 0.03% 583
2019
Q3
$139M Buy
+2,749,861
New +$139M 0.02% 758